Alastair E. Lacey
Alastair E. Lacey has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Andrew Crombie
Microbial Screening Technologies Pty. Ltd, Smithfield, NSW 2164, Australia
2 shared publications - Andrew M. Piggott
School of Natural Sciences, Macquarie University, Sydney, NSW 2109, Australia
2 shared publications - Daniel Vuong
School of Natural Sciences, Macquarie University, Sydney, NSW 2109, Australia
2 shared publications - Ernest Lacey
School of Natural Sciences, Macquarie University, Sydney, NSW 2109, Australia
2 shared publications Ashli Lau
School of Molecular Sciences, The University of Western Australia, Perth, WA 6009, Australia
1 shared publication- Fraser Windsor
School of Molecular Sciences, The University of Western Australia, Perth, WA 6009, Australia
1 shared publication
Latest Publications
- Open Access
- 24 October 2024
- Published by Royal Society of Chemistry (RSC) in Chemical Science
- Vol. 15 (45) , 18872-18880
The aquastatin biosynthetic gene cluster encodes a versatile polyketide synthase capable of synthesising heteromeric depsides with diverse alkyl side chains
The aqu BGC from Austroacremonium gemini encodes a versatile polyketide synthase capable of synthesising heteromeric depsides with diverse alkyl side chains.
- 24 October 2024
- Published by Royal Society of Chemistry (RSC) in Chemical Science
- Vol. 15 (45) , 18872-18880
Open AccessThe aquastatin biosynthetic gene cluster encodes a versatile polyketide synthase capable of synthesising heteromeric depsides with diverse alkyl side chains
The aqu BGC from Austroacremonium gemini encodes a versatile polyketide synthase capable of synthesising heteromeric depsides with diverse alkyl side chains.
- 4 April 2018
- Published by Royal Society of Chemistry (RSC) in Organic & Biomolecular Chemistry
- Vol. 16 (16) , 3038-3051
Expanding antibiotic chemical space around the nidulin pharmacophore
Reinvestigating antibiotic scaffolds that were identified during the Golden Age of antibiotic discovery, but have long since been “forgotten”, has proven to be an effective strategy for delivering next-generation antibiotics capable of combatting multidrug-resistant superbugs. In this study, we have revisited the trichloro-substituted depsidone, nidulin, as a selective and unexploited antibiotic lead produced by the fungus Aspergillus unguis. Manipulation of halide ion concentration proved to be a powerful tool for modulating secondary metabolite production and triggering quiescent pathways in A. unguis. Supplementation of the culture media with chloride resulted in a shift in co-metabolite profile to dichlorounguinols and nornidulin at the expense of the non-chlorinated parent, unguinol. Surprisingly, only marginal enhancement of nidulin was observed, suggesting O-methylation may be rate-limiting. Similarly, supplementation of the media with bromide led to the production of the corresponding bromo-analogues, but also resulted in a novel family of depsides, the unguidepsides. Unexpectedly, depletion of chloride from the media halted the biosynthesis of the non-chlorinated parent compound, unguinol, and redirected biosynthesis to a novel family of ring-opened analogues, the unguinolic acids. Supplementation of the media with a range of unnatural salicylic acids failed to yield the corresponding nidulin analogues, suggesting the compounds may be biosynthesised by a single polyketide synthase. In total, 12 new and 11 previously reported nidulin analogues were isolated, characterised and assayed for in vitro activity against a panel of bacteria, fungi and mammalian cells, providing a comprehensive structure–activity profile for the nidulin scaffold.
- 4 April 2018
- Published by Royal Society of Chemistry (RSC) in Organic & Biomolecular Chemistry
- Vol. 16 (16) , 3038-3051
Expanding antibiotic chemical space around the nidulin pharmacophore
Reinvestigating antibiotic scaffolds that were identified during the Golden Age of antibiotic discovery, but have long since been “forgotten”, has proven to be an effective strategy for delivering next-generation antibiotics capable of combatting multidrug-resistant superbugs. In this study, we have revisited the trichloro-substituted depsidone, nidulin, as a selective and unexploited antibiotic lead produced by the fungus Aspergillus unguis. Manipulation of halide ion concentration proved to be a powerful tool for modulating secondary metabolite production and triggering quiescent pathways in A. unguis. Supplementation of the culture media with chloride resulted in a shift in co-metabolite profile to dichlorounguinols and nornidulin at the expense of the non-chlorinated parent, unguinol. Surprisingly, only marginal enhancement of nidulin was observed, suggesting O-methylation may be rate-limiting. Similarly, supplementation of the media with bromide led to the production of the corresponding bromo-analogues, but also resulted in a novel family of depsides, the unguidepsides. Unexpectedly, depletion of chloride from the media halted the biosynthesis of the non-chlorinated parent compound, unguinol, and redirected biosynthesis to a novel family of ring-opened analogues, the unguinolic acids. Supplementation of the media with a range of unnatural salicylic acids failed to yield the corresponding nidulin analogues, suggesting the compounds may be biosynthesised by a single polyketide synthase. In total, 12 new and 11 previously reported nidulin analogues were isolated, characterised and assayed for in vitro activity against a panel of bacteria, fungi and mammalian cells, providing a comprehensive structure–activity profile for the nidulin scaffold.